Results 41 to 50 of about 5,793,605 (328)

Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use

Emerging Infectious Diseases, 2005
Few long-term multicenter investigations have evaluated the relationships between aggregate antimicrobial drug use in hospitals and bacterial resistance. We measured fluoroquinolone use from 1999 through 2003 in a network of US hospitals. The percentages
Conan MacDougall, Spencer E. Harpe, J. Patrick Powell, Christopher K. Johnson, Michael B. Edmond, Ron E. Polk   +5 more
doaj   +1 more source

Overcoming challenges in metagenomic AMR surveillance with nanopore sequencing: a case study on fluoroquinolone resistance. [PDF]

Front Microbiol
INTRODUCTION: Antimicrobial resistance is an alarming public health problem, and comprehensive surveillance across environments is required to reduce its impact.
Bloemen B, Gand M, Ringenier M, Bogaerts B, Vanneste K, Marchal K, Roosens NHC, Dewulf J, Boyen F, De Keersmaecker SCJ.   +9 more
europepmc   +2 more sources

Trends in Bacterial Resistance to Fluoroquinolones [PDF]

Clinical Infectious Diseases, 1997
The emergence of resistance to fluoroquinolones in virtually all species of bacteria was recognized soon after the introduction of these compounds for clinical use more than 10 years ago. Various resistance mechanisms, often interdependent, may explain different levels of resistance.
J F, Acar, F W, Goldstein
openaire   +2 more sources

New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. [PDF]

PLoS ONE, 2012
Fluoroquinolone antibiotics are among the most potent second-line drugs used for treatment of multidrug-resistant tuberculosis (MDR TB), and resistance to this class of antibiotics is one criterion for defining extensively drug resistant tuberculosis ...
Seidu Malik, Melisa Willby, David Sikes, Oleg V Tsodikov, James E Posey   +4 more
doaj   +1 more source

Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) [PDF]

, 2014
Portugal - EARS-Net Management Team & National representatives of EARS-Net (Manuela Caniça, José Artur Paiva, Vera Manageiro, Eugénia Ferreira)The results presented in this report are based on antimicrobial resistance data from invasive isolates reported
European Antimicrobial Resistance Surveillance Network (EARS-Net)
core   +1 more source

Antimicrobial susceptibility of Mycoplasma genitalium isolates from Pretoria, South Africa in 2012 and 2016

Southern African Journal of Infectious Diseases, 2018
Background: Mycoplasma genitalium is a sexually transmitted pathogen associated with non-gonococcal urethritis and cervicitis. Azithromycin regimens have been considered first-line treatment for M.
Marie C. Le Roux, Maanda Mafunise, Barbara E. de Villiers, Ramalau M. Ditsele   +3 more
doaj   +1 more source

Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis.

The Lancet Microbe
BACKGROUND Over the past 5 years, since publication of the initial review, studies have provided additional data on macrolide and fluoroquinolone resistance in Mycoplasma genitalium, including data from regions previously lacking this information.
Teck-Phui Chua, L. Vodstrcil, Gerald L. Murray, E. Plummer, J. S. Jensen, M. Unemo, Eric P. F. Chow, N. Low, D. Whiley, Emma L. Sweeney, J. Hocking, J. Danielewski, S. Garland, C. Fairley, Lei Zhang, C. Bradshaw, Dorothy A. Machalek   +16 more
semanticscholar   +1 more source

Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study

BMC Public Health, 2019
Background The frequency of antimicrobial resistance has steadily increased worldwide, induced by inappropriate use of antibiotics in a variety of settings.
Fumitaka Terahara, Hiroshi Nishiura
doaj   +1 more source

Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance

ACS Infectious Diseases
Beyond their requisite functions in many critical DNA processes, the bacterial type II topoisomerases, gyrase and topoisomerase IV, are the targets of fluoroquinolone antibacterials.
Jessica A Collins, Neil Osheroff
semanticscholar   +1 more source

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use

BMC Infectious Diseases, 2011
Background Antibiotic resistance has necessitated fluoroquinolone use but little is known about the selective forces and resistance trajectory in malaria-endemic settings, where selection from the antimalarial chloroquine for fluoroquinolone-resistant ...
Lamikanra Adebayo, Crowe Jennifer L, Lijek Rebeccah S, Odetoyin Babatunde W, Wain John, Aboderin A Oladipo, Okeke Iruka N   +6 more
doaj   +1 more source